Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial.
已取消20由 哒哒 发布于 2026/3/14 21:27:06
DOI:10.4244/EIJV7I9A168
作者:Dariusz Dudek,?Yoshinobu Onuma,?John A Ormiston,?Leif Thuesen,?Karine Miquel-Hebert,?Patrick W Serruys
文献类型:期刊论文
补充材料:只需要正文 管理员驳回:此文献全文只有两页,应助文件是正确且完整的